Galletta Christopher
SEC CIK 1486099 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRVI | Trevi Therapeutics, Inc. | See Remarks | 26.1K | — | — | 2 | 2024-12-13 | 2025-12-02 |
Most active insiders at TRVI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Heffernan Michael Thomas | Dir | — | $595.8K |
| 2 | Galletta Christopher | See Remarks | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-03 | 2025-12-02 | TRVI | Trevi Therapeutics, Inc. | Galletta Christopher | See Remarks | M - OptEx | $0.51 | +4,225 | 26.1K | +19% | +$2,155 |
| D | 2024-12-17 | 2024-12-13 | TRVI | Trevi Therapeutics, Inc. | Galletta Christopher | See Remarks | M - OptEx | $0.51 | +15.0K | 19.9K | +304% | +$7,650 |
Purchase Sale Sale after option exercise All abbreviations